Cited by 171Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysHeat shock proteins research

The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.

The role of ubiquitin modification in the regulation of p53

Open access

Hock, Andreas K., Vousden, Karen H.·2014·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

DOI 10.1016/j.bbamcr.2013.05.022

Open this paper in CoChat — free account Open PDF

Abstract

The p53 tumor suppressor protein is involved in regulating a wide variety of stress responses, from senescence and apoptosis to more recently discovered roles in allowing adaptation to metabolic and oxidative stress. After 34years of research, significant progress has been made in unraveling the complexity of the p53 network, and it is clear that the regulation of p53 protein stability is critical in the control of p53 activity. This article focuses on our current understanding of how the level and activity of p53 is controlled by this seemingly simple mechanism. This article is part of a Special Issue entitled: Ubiquitin-Proteasome System. Guest Editors: Thomas Sommer and Dieter H. Wolf.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2013.05.022

Cites

269 of 269 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citation
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citation
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO
Hoege, C., Pfander, B., Moldovan, G., Pyrowolakis, G., & Jentsch, S. (2002) · Nature · doi:10.1038/nature00991 · Cited by 2,202
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820

Show all 275 references

Sorted by citations

Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Self-citation
Control of protein stability by post-translational modifications
Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 896
TP53: an oncogene in disguise
Soussi, T., & Wiman, K. G. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.53 · Cited by 305
Therapeutic strategies to overcome taxane resistance in cancer
Das, T., Anand, U., Pandey, S. K., Ashby, C. R., Assaraf, Y. G., Chen, Z., & Dey, A. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100754 · Cited by 262
The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
Liu, J., Zhang, C., Wang, J., Hu, W., & Feng, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218387 · Cited by 255
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Zhu, H., Gao, H., Ji, Y., Zhou, Q., Du, Z., Tian, L., Jiang, Y., Yao, K., & Zhou, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01314-3 · Cited by 223
Control of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 227
Self-citation
Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging
Turi, Z., Lacey, M., Mistrík, M., & Moudrý, P. (2019) · Aging · doi:10.18632/aging.101922 · Cited by 220
Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
Pal, A., Young, M. A., & Donato, N. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1211 · Cited by 201
Antioxidants and HNE in redox homeostasis
Łuczaj, W., Gęgotek, A., & Skrzydlewska, E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.033 · Cited by 201
The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
Oršolić, I., Jurada, D., Pullen, N., Oren, M., Eliopoulos, A. G., & Volarević, S. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.004 · Cited by 170
Limiting the power of p53 through the ubiquitin proteasome pathwayPreprint
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 170
Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions
Khan, H. Z., Reale, M., Ullah, H., Sureda, A., Tejada, S., Wang, Y., Zhang, Z., & Xiao, J. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.007 · Cited by 157
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Bursać, S., Brdovčak, M. C., Donati, G., & Volarević, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.014 · Cited by 166
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same EndPreprint
Wasylishen, A. R., & Lozano, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026211 · Cited by 131
SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence
Johmura, Y., Sun, J. M., Kitagawa, K., Nakanishi, K., Kuno, T., Naiki‐Ito, A., Sawada, Y., Miyamoto, T., Okabe, A., Aburatani, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10574 · Cited by 117
DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes
Vergoni, B., Cornejo, P.-J., Gilleron, J., Djedaini, M., Ceppo, F., Jacquel, A., Bouget, G., Ginet, C., Gonzalez, T., Maillet, J., et al. (2016) · Diabetes · doi:10.2337/db16-0014 · Cited by 126
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
Feng, Y., Liu, X., Liu, T., Ji, Q., Wu, Y., Li, J., Gao, W., Zhang, Y. Y., La, T., Tabatabaee, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18735-8 · Cited by 119
A comprehensive method for detecting ubiquitinated substrates using TR-TUBE
Yoshida, Y., Saeki, Y., Murakami, A., Kawawaki, J., Tsuchiya, H., Yoshihara, H., Shindo, M., & Tanaka, K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422313112 · Cited by 119
Role of the nucleus in apoptosis: signaling and execution
Prokhorova, E. A., Zamaraev, A. V., Kopeina, G. S., Zhivotovsky, B., & Lavrik, I. N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2031-y · Cited by 116
Recognition of Client Proteins by the Proteasome
Yu, H., & Matouschek, A. T. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033719 · Cited by 112
p53 stability is regulated by diverse deubiquitinating enzymes
Kwon, S., Saindane, M., & Baek, K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.08.001 · Cited by 112
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Guo, J., Wu, Y., Du, J., Yang, L., Chen, W., Gong, K., Dai, J., Miao, S., Jin, D., & Xi, S. (2018) · Oncogenesis · doi:10.1038/s41389-018-0054-6 · Cited by 115
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
Cui, D., Qu, R., Liu, D., Xiong, X., Liang, T., & Zhao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775507 · Cited by 112
C16-ceramide is a natural regulatory ligand of p53 in cellular stress response
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Szulc, Z. M., Knagge, K. J., Kirchner, D. R., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2018) · Nature Communications · doi:10.1038/s41467-018-06650-y · Cited by 103
Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
Herrero, A. B., Rojas, E. A., Misiewicz-Krzemińska, I., Krzemiński, P., & Gutierrez, N. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122003 · Cited by 102
The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
Zhang, C., Liu, J., Wang, J., Zhang, T., Xu, D., Hu, W., & Feng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648808 · Cited by 100
Ubiquitination and deubiquitination: Implications on cancer therapy
Dagar, G., Kumar, R., Yadav, K. K., Singh, M. K., & Pandita, T. K. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194979 · Cited by 96
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 88
Prolyl isomerases in gene transcription
Hanes, S. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.028 · Cited by 87
Regulation of Mutant p53 Protein Expression
Vijayakumaran, R., Tan, K. H., Miranda, P. J., Haupt, S., & Haupt, Y. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00284 · Cited by 87
Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3
Hu, D., Su, C., Jiang, M., Shen, Y., Shi, A., Zhao, F., Chen, R., Shen, Z., Bao, J., & Tang, W. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.169 · Cited by 86
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
Abbas, R., & Larisch, S. (2021) · Cells · doi:10.3390/cells10123465 · Cited by 91
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Cui, D., Xiong, X., Shu, J., Dai, X.-Q., Sun, Y., & Zhao, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.12.032 · Cited by 82
Dynamics of p53: A Master Decider of Cell Fate
Luo, Q., Beaver, J. M., Liu, Y., & Zhang, Z. (2017) · Genes · doi:10.3390/genes8020066 · Cited by 78
A patent review of the ubiquitin ligase system: 2015–2018
Li, X., Ekinci, E., Rohondia, S. O., Wang, J., Liu, J., & Dou, Q. P. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1549229 · Cited by 76
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
Pecháčková, S., Burdová, K., Benada, J., Kleiblová, P., Jeníková, G., & Macůrek, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7363 · Cited by 76
Development of inhibitors in the ubiquitination cascade
Zhang, W., & Sidhu, S. S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.003 · Cited by 77
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
Portman, N., Milioli, H. H., Alexandrou, S., Coulson, R. S., Yong, A., Fernandez, K. J., Chia, K. M., Halilovic, E., Segara, D., Parker, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01318-2 · Cited by 65
Ceramide Signaling and p53 Pathways
Jeffries, K. A., & Krupenko, N. I. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.011 · Cited by 68
Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53
Piao, S., Pei, H. Z., Huang, B., & Baek, S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.011 · Cited by 65
Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer
Balamurugan, K., Sehareen, S., Sharan, S., Krishnamurthy, S., Tang, W., McKennett, L., Padmanaban, V., Czarra, K., Ewald, A. J., Ueno, N. T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.156057 · Cited by 62
Specificity and disease in the ubiquitin system
Chaugule, V. K., & Walden, H. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150209 · Cited by 65
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 59
Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment
Ray, A., Rana, S., Banerjee, D., Mitra, A., Datta, R., Naskar, S., & Sarkar, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.011 · Cited by 58
The tumour suppressor CYLD regulates the p53 DNA damage response
Fernández‐Majada, V., Welz, P.-S., Ermolaeva, M., Schell, M. J., Adam, A. C., Dietlein, F., Komander, D., Büttner, R., Thomas, R. K., Schumacher, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12508 · Cited by 57
Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10
Zhang, W., Sartori, M. A., Makhnevych, T., Federowicz, K., Dong, X., Liu, L., Nim, S., Dong, A., Yang, J., Li, Y., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.025 · Cited by 56
Tumor suppressor p53 cross-talks with TRIM family proteins
Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 57
Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint
Lim, K., Song, M.-H., & Baek, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2129-2 · Cited by 52
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 53
Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins
Rodríguez, J. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.005 · Cited by 48
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a
Sparks, A., Dayal, S., Das, J., Robertson, P., Ménendez, S., & Saville, M. K. (2013) · Oncogene · doi:10.1038/onc.2013.413 · Cited by 49
Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation
Xu, J., Su, C., Zhao, F., Tao, J., Hu, D., Shi, A., Pan, J., & Zhang, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.142 · Cited by 46
Ubiquitin-specific Peptidase 42 (USP42) Functions to Deubiquitylate Histones and Regulate Transcriptional Activity
Hock, A. K., Vigneron, A. M., & Vousden, K. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589267 · Cited by 44
Self-citation
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells
Yang, H., Yu, S., Wang, W., Li, X., Hou, Y., Liu, Z., Shi, Y., Mu, K., Niu, G., Xu, J., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2016.12.002 · Cited by 46
The regulation of radiosensitivity by p53 and its acetylation
Zhang, J., Shen, L., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.015 · Cited by 45
MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
Marcar, L., Ihrig, B., Hourihan, J. M., Bray, S. E., Quinlan, P., Jordan, L. B., Thompson, A. M., Hupp, T. R., & Meek, D. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127713 · Cited by 42
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 45
Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway
Zhang, Z., Liu, P., Wang, J., Gong, T., Zhang, F., Ma, J., & Han, N. (2015) · Medical Oncology · doi:10.1007/s12032-015-0609-8 · Cited by 43
p53 regulation upon genotoxic stress: intricacies and complexities
Kumari, R., Kohli, S., & Das, S. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969653 · Cited by 41
Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
Swetzig, W. M., Wang, J., & Das, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7533 · Cited by 44
OrfX, a Nucleomodulin Required for Listeria monocytogenes Virulence
Prokop, A., Gouin, E., Villiers, V., Nahori, M., Vincentelli, R., Duval, M., Cossart, P., & Dussurget, O. (2017) · mBio · doi:10.1128/mbio.01550-17 · Cited by 40
The Role of MDM2 in Promoting Genome Stability versus Instability
Saadatzadeh, M. R., Elmi, A. N., Pandya, P. H., Bijangi‐Vishehsaraei, K., Ding, J., Stamatkin, C. W., Cohen‐Gadol, A., & Pollok, K. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102216 · Cited by 44
Anatomy of Mdm2 and Mdm4 in evolution
Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40
New Insights Into the Role of Ubiquitylation of Proteins
McDowell, G. S., & Philpott, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.02.002 · Cited by 37
A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction
Surmiak, E., Twarda‐Clapa, A., Żak, K. M., Musielak, B., Tomala, M. D., Kubica, K., Grudnik, P., Madej, M., Jabłoński, M., Potempa, J., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00596 · Cited by 36
P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors
do Patrocinio, A. B., Rodrigues, V., & Guidi Magalhães, L. (2022) · ACS Omega · doi:10.1021/acsomega.1c04726 · Cited by 36
An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53
Huang, Y., Jiao, Z., Fu, Y., Hou, Y., Sun, J., Hu, F., Yu, S., Gong, K., Liu, Y., & Zhao, G. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116121 · Cited by 33
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 38
IL-17A Promotes Intracellular Growth of Mycobacterium by Inhibiting Apoptosis of Infected Macrophages
Cruz, A., Ludovico, P., Torrado, E., Gama, J. B., Sousa, J., Gaifem, J., Appelberg, R., Rodrigues, F. J. S., Cooper, A. M., Pedrosa, J., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00498 · Cited by 35
Two mammalian homologs of yeast Rad23, HR23A and HR23B, as multifunctional proteins
Yokoi, M., & Hanaoka, F. (2016) · Gene · doi:10.1016/j.gene.2016.10.027 · Cited by 34
The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humansPreprint
Coffill, C. R., Lee, A., Siau, J. W., Chee, S. M. Q., Joseph, T. L., Tan, Y. S., Madhumalar, A., Tay, B.-H., Brenner, S., Verma, C. S., et al. (2016) · Genes & Development · doi:10.1101/gad.274118.115 · Cited by 34
FBXL6 degrades phosphorylated p53 to promote tumor growth
Li, Y., Cui, K., Zhang, Q., Lin, X., Lin, X., Tang, Y., Prochownik, E. V., & Li, Y. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00739-6 · Cited by 34
Identification of small-molecule inhibitors of USP2a
Tomala, M. D., Magiera‐Mularz, K., Kubica, K., Krzanik, S., Zieba, B. J., Musielak, B., Pustuła, M., Popowicz, G. M., Sattler, M., Dubin, G., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.009 · Cited by 32
1,4,5-Trisubstituted Imidazole-Based p53–MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers
Twarda‐Clapa, A., Krzanik, S., Kubica, K., Guzik, K., Łabuzek, B., Neochoritis, C. G., Khoury, K., Kowalska, K., Czub, M., Dubin, G., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00104 · Cited by 31
Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues
Qian, S., Zhan, X., Lu, M., Li, N., Long, Y., Li, X., Desiderio, D. M., & Zhan, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00328 · Cited by 31
WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway
Sun, Y., Cao, L., Sheng, X., Chen, J., Zhou, Y., Yang, C., Deng, T., Ma, H., Feng, P., Liu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.162 · Cited by 31
The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution
Román-Trufero, M., & Dillon, N. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1058751 · Cited by 29
Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Zanjirband, M., & Rahgozar, S. (2019) · Current Drug Targets · doi:10.2174/1389450120666190402120701 · Cited by 31
p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD
Mizuno, S., Ishizaki, T., Kadowaki, M., Akai, M., Shiozaki, K., Iguchi, M., Oikawa, T., Nakagawa, K., Osanai, K., Toga, H., et al. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.012 · Cited by 29
Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis
Zhang, L., Li, L., Chen, X., Yuan, S., Xu, T., Zhao, W., Li, M., Wang, F., Hoffman, R. M., & Jia, L. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154493 · Cited by 29
Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies
Andrews, J. L., Goodfellow, F. J., Matosin, N., Snelling, M., Newell, K. A., Huang, X., & Fernandez, F. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.01.009 · Cited by 28
Oral Papillomatosis: Its Relation with Human Papilloma Virus Infection and Local Immunity—An Update
ANDREI, E. C., Baniţă, I. M., Munteanu, M. C., Busuioc, C. J., Mateescu, G.-O., Mălin, R. D., & Pisoschi, C. G. (2022) · Medicina · doi:10.3390/medicina58081103 · Cited by 29
SIRT3 increases cisplatin sensitivity of small-cell lung cancer through apoptosis
Guo, R., Li, Y., Xue, Y., Chen, Y., Li, J., Deng, X. L., Su, J., Liu, Y., & Sun, L. (2020) · Gene · doi:10.1016/j.gene.2020.144629 · Cited by 27
Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo
Seo, S. U., Woo, S. M., Kim, S., Park, J., Lee, H., Bae, Y., Kim, S., Im, S., Seo, J. H., Min, K., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02088-7 · Cited by 26
Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells
Ray, D., Ray, P., Ferrer-Torres, D., Wang, Z., Nancarrow, D. J., Yoon, H., Martinho, M. S., Hinton, T., Owens, S. R., Thomas, D. G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.10.040 · Cited by 25
UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation
Cao, J., Nie, G., Hu, H., Zhang, X., Ni, C., Huang, Z., Qiao, G., & Ouyang, L. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-516 · Cited by 25
Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
Zhou, C., Zhu, Y., Lu, B., Zhao, W., & Zhao, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9277 · Cited by 24
Deubiquitinating enzyme USP9X regulates cellular clock function by modulating the ubiquitination and degradation of a core circadian protein BMAL1
Zhang, Y., Duan, C., Yang, J., Chen, S., Liu, Q. L., Zhou, L., Huang, Z., Xu, Y., & Xu, G. (2018) · Biochemical Journal · doi:10.1042/bcj20180005 · Cited by 23
MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance
Lu, J., Li, Y., Wu, Y., Zhou, S., Duan, C., Dong, Z., Kang, T., & Tang, F. (2018) · Theranostics · doi:10.7150/thno.28228 · Cited by 22
Retracted
The Ins and Outs of HOPS/TMUB1 in biology and pathology
Fazia, M. A. D., Castelli, M., Piobbico, D., Pieroni, S., & Servillo, G. (2020) · FEBS Journal · doi:10.1111/febs.15539 · Cited by 21
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Sengupta, S., Ghufran, S. M., Khan, A. A., Biswas, S., & Roychoudhury, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02831-4 · Cited by 20
RNF125 is a Ubiquitin-Protein Ligase that Promotes p53 Degradation
Yang, L., Zhou, B., Li, X., Lu, Z., Li, W., Huo, X., & Miao, Z. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369691 · Cited by 21
TP53 in Myelodysplastic Syndromes
Jiang, Y., Gao, S., Soubise, B., Douet‐Guilbert, N., Liu, Z., & Troadec, M. (2021) · Cancers · doi:10.3390/cancers13215392 · Cited by 22
Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death
Nakamura, M., Sugimoto, H., Ogata, T., Hiraoka, K., Yoda, H., Sang, M., Sang, M., Zhu, Y., Yu, M., Shimozato, O., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.40 · Cited by 19
Probing protein ubiquitination in live cells
Qin, W., Steinek, C., Kolobynina, K. G., Forné, I., Imhof, A., Cardoso, M. C., & Leonhardt, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac805 · Cited by 20
Tumour suppressors and cellular senescence
Chan, A. S. L., Mowla, S. N., Arora, P., & Jat, P. (2014) · IUBMB Life · doi:10.1002/iub.1335 · Cited by 20
Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53–MDM2 interaction in a hydroxylase-independent manner
Xu, Y., Gao, Q., Xue, Y., Li, X., Xu, L., Li, C., Qin, Y., & Fang, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007181 · Cited by 17
Poly(ADP-ribosyl)ation of p53 Contributes to TPEN-Induced Neuronal Apoptosis
Kim, H.-L., Ra, H., Kim, K.-R., Lee, J.-M., Im, H., & Kim, Y. H. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2142 · Cited by 17

Authors: Hock, A. K., & Vousden, K. H.
Affiliations: Cancer Research UK Scotland Institute (GB)
Corresponding author: Vousden, Karen H.
ORCID: Vousden, Karen H.
Venue: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher: Elsevier BV
Published: 2014-01
Volume: 1843
Issue: 1
Pages: 137-149
ISSN: 0167-4889 (ISSN-L)
DOI: 10.1016/j.bbamcr.2013.05.022
OpenAlex: W2062976534
Cited by: 168
References: 275
Citations by year: 2026: 4 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 27 · 2020: 9 · 2019: 9 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 19 · 2014: 15
FWCI: 1.94
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: CR-UK
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p53, ubiquitin modification, protein stability, ubiquitin-proteasome system, tumor suppressor regulation, apoptosis, senescence, oxidative stress, metabolic stress, stress response
MeSH terms: Animals, Humans, Protein Processing, Post-Translational, Transcriptional Activation, Tumor Suppressor Protein p53, Ubiquitin, Proto-Oncogene Proteins c-mdm2, Ubiquitination, Protein Stability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of ubiquitin modification in the regulation of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks